MAJOR ADVERSE CARDIOVASCULAR AND CEREBROVASCULAR EVENTS (MACCE)

Clinical trials for MAJOR ADVERSE CARDIOVASCULAR AND CEREBROVASCULAR EVENTS (MACCE) explained in plain language.

Never miss a new study

Get alerted when new MAJOR ADVERSE CARDIOVASCULAR AND CEREBROVASCULAR EVENTS (MACCE) trials appear

Sign up with your email to follow new studies for MAJOR ADVERSE CARDIOVASCULAR AND CEREBROVASCULAR EVENTS (MACCE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

ER doctors test new timing for heart attack drugs to reduce bleeding risks

Disease control Recruiting now

This study looks at whether giving two blood-thinning medications together in the emergency room is safe and effective for people having a heart attack. Researchers will review the medical records of 200 patients to see if this earlier timing leads to fewer serious bleeding event…

Matched conditions: MAJOR ADVERSE CARDIOVASCULAR AND CEREBROVASCULAR EVENTS (MACCE)

Sponsor: Jordan Collaborating Cardiology Group • Aim: Disease control

Last updated Apr 01, 2026 14:40 UTC

MAJOR ADVERSE CARDIOVASCULAR AND CEREBROVASCULAR EVENTS (MACCE)

Get alerted when new MAJOR ADVERSE CARDIOVASCULAR AND CEREBROVASCULAR EVENTS (MACCE) trials appear

ER doctors test new timing for heart attack drugs to reduce bleeding risks